Nventa Biopharmaceuticals Corporation
 Nventa Biopharmaceuticals Corporation was a Canadian incorporated biopharmaceutical company headquartered in San Diego California developing therapeutics for the treatment of viral infections and cancer focusing on diseases caused by human papillomavirus (HPV). Nventa is currently the only company applying heat shock protein (Hsp) technology to target the over 20 million Americans already infected with HPV.